RA Capital
Investor profile
Venture capital
RA Capital has backed 2 European tech companies across 2 funding rounds between 2023 and 2025, joining rounds totalling €261M. Most active in Healthtech. Data as of 4 Nov 2026.
Deals
2
distinct rounds
Companies
2
backed
Active span
2023–2025
3 yrs
Total round €
€261M
sum of rounds joined
Deals by year
distinct rounds / yearRA Capital — deals by year — interactive chart.
Data table
| RA Capital — deals by year | |
|---|---|
| 2023 | 1 |
| 2025 | 1 |
Top sectors
by dealsRA Capital — top sectors — interactive chart.
Data table
| RA Capital — top sectors | |
|---|---|
| Healthtech | 2 |
Stages
by dealsRA Capital — stages — interactive chart.
Data table
| RA Capital — stages | |
|---|---|
| Other | 1 |
| Series A | 1 |
Countries
by dealsRA Capital — countries — interactive chart.
Data table
| RA Capital — countries | |
|---|---|
| UK | 2 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Compass Pathways | UK | 1 | €261M |
| Alchemab Therapeutics | UK | 1 | €0 |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Compass Pathways | Other | €261M | 2023-08 |